Table 3.

Safety monitoring guidelines for teriflunomide.

Timeframe	Suggested parameters to monitor
Prior to initiation	CBC and LFTs (within 6 months prior to initiation)
	Measure blood pressure
	Screen for latent tuberculosis
After initiation	Monthly LFTs for the first 6 months, then every 6 months thereafter
	CBC should be assessed if signs/symptoms of hematologic toxicity
	Monitor blood pressure periodically

CBC, complete blood count; LFT, liver function test.